M Lombard, I Salard, MA Sari, D Mansuy… - Archives of Biochemistry …, 2011 - Elsevier ... Available online 15 January 2011. Abstract. Fexofenadine, an antihistaminedrug used in allergic rhinitis treatment, can be produced by oxidative biotransformation of terfenadine by Streptomyces platensis, which involves three consecutive oxidation reactions. ... All 2 versions
MJA Walker - Trends in pharmacological sciences, 2011 - Elsevier ... After a lengthy period of analytic study, which involved choosing appropriate bioassays and synthesizing selective putative agonists and antagonists, he achieved his goal of a selective H2 antihistaminedrug some 9 years later [26] and [27] with the aid of critical medicinal ... Related articles - All 3 versions
JP Berninger, B Du, KA Connors… - Environmental …, 2011 - Wiley Online Library ... been identified in field studies. One drug in particular, the antihistamine diphenhydramine (DPH), Page 4. Accep ... Diphenhydramine is a first generation antihistaminedrug found in many common over-the-counter formulations (Table 1), and crosses the blood-brain barrier [15]. ... Related articles - All 2 versions
GC Bloomfield, I Bruce, JF Hayler… - US Patent App. 13/ …, 2011 - Google Patents Page 1. US 20110124693A1 (i9) United States (12) Patent Application Publication oo) Pub. No.: US 2011/0124693 Al Bloomfield et al. (43) Pub. Date: May 26,2011 (54) 5-PHENYL-4-METHYL-THIAZOL-2-YL- AMINE DERIVATIVES ... All 3 versions
MK Church - Inflammation Research, 2011 - Springer ... The H1-antihistamine used in this study, bilastine (2-[4- (2-(4-(1-(2-ethoxyethyl)-1H-benzimidazol- 2-yl)piperidin- 1-yl)ethyl)phenyl]-2-methylpropionic acid), is a new antihistaminedrug undergoing clinical development by Faes Farma, SA, Spain, approved recently for ...